Intrexon | XON - Trade Creditors


Intrexon reported $4.85M in Trade Creditors for its fiscal quarter ending in June of 2024.





Trade Creditors Change Date
Agenus USD 58.98M 12.1M Jun/2026
Alaunos Therapeutics USD 400K 213K Mar/2026
Amgen USD 2.86B 16.65B Jun/2026
Anika Therapeutics USD 6.24M 103K Jun/2026
Arrowhead Research USD 27.78M 2.97M Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Heron Therapeutics USD 11.64M 2.67M Jun/2026
Incyte USD 1.39B 1.16B Jun/2026
Intrexon USD 4.85M 3.12M Jun/2024
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
Ligand Pharmaceuticals USD 9.4M 27.7M Jun/2026
MacroGenics USD 3.44M 845K Jun/2026
MannKind USD 11.04M 5.1M Jun/2026
Merck USD 3.83B 36M Jun/2026
Novartis USD 4.26B 64M Jun/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Roche Holding CHF 5.54B 237M Jun/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Thermo Fisher Scientific USD 3.34B 278M Mar/2026
Veracyte USD 8.02M 1.12M Jun/2026
Xencor USD 12.65M 4.73M Jun/2026